American Journal of Infection Control

There is a lack of attention given to research on infection prevention and control and practical guidance among people and their lives outside of health care settings, especially in impoverished communities where people live, work, and play. To stop

The Emerging Infections Program (EIP) of the Centers for Disease Control and Prevention (CDC) recently estimated from data collected at designated EIP locations that there were ∼236,000 cases of healthcare-associated Clostridioides difficile

Negative outcomes associated with COVID-19 in pregnant patients make vaccination an imperative precaution for this patient population. Pregnant patients were excluded from the randomized clinical trials conducted early in the pandemic to determine

The coronavirus disease (COVID-19) is a highly contagious illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 Among the primary measures to reduce COVID-19 dissemination, multiple health authorities, including the

Antibiotic overuse puts patients at risk for adverse events and contributes to global antibiotic resistance. More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.1

The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) has occurred at such a swift pace that it has crippled worldwide supply chains and has most critically

Since the emergence of coronavirus disease 2019 (COVID-19) in February 2020, the number of pregnant women infected with the virus and delivering by cesarean section has been steadily increasing in South Korea.1 Additionally, pregnancy is considered a

Annual influenza vaccination is recommended for all health-care personnel by the Healthcare Infection Control Practices Advisory Committee and Advisory Committee on Immunization Practices.1 Several barriers to vaccination have been previously

Surgical Site Infections (SSIs) are a significant issue that persists throughout operating suites worldwide. Despite global medical advancements, SSIs still cause substantial morbidity along with a significant cost burden in the United States that is

Surgical Site Infections (SSIs) are a significant issue that persists throughout operating suites worldwide. Despite global medical advancements, SSIs still cause substantial morbidity along with a significant cost burden in the United States that is